Abstract
Cancer is a significant health problem worldwide and forms through orchestrated and highly complex biological processes. This process is mediated through biophysical and biochemical signals that develop from within the tumor microenvironment. Although two-dimensional culture systems of established breast cancer cell lines are the most widely used model for cancer biology and preclinical drug assessments, it poorly mimics the behavior of cancer cells in vivo and fails to reproduce the in vivo tumor microenvironment, and accordingly, the data it produces is not always predictive. Effective therapeutic strategies require a cost-efficient in vitro model that can more accurately resemble the in vivo tumor microenvironment, thus permitting a variety of in vitro studies. Rapid prototyping (RP) is one of the most promising techniques for designing and producing three-dimensional (3D) systems (hydrogels, scaffolds) for drug efficacy analysis, developing drug delivery systems, and tissue engineering applications. The application of 3D bioprinting in engineering a cancer cell microenvironment will be the focus of this chapter. We will describe previous model systems used to understand cancer cell behavior. In particular, bioprinting methods and strategies that emphasize recreation of a cancer microenvironment that promotes cultured cancer cells to express a more relevant phenotype will be examined. Our focus will be on the 3D bioprinted models that serve as a predictive model for understanding mechanisms leading to cancer cell metastasis, permit real-time study of cell–cell interactions, enable the analysis of growth factors and cytokine expression that supports tumor cell growth or survival, and the molecular cross-talk between tumor and stromal cells. The chapter will conclude with an assessment of the current state-of-the-art and future prospects.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Siegel RL, Miller KD, Jemal A (2017) Cancer statistics. CA Cancer J Clin 67:7–30
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90. [PubMed: 21296855]
Luengo-Fernandez R, Leal J, Gray A et al (2013) Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 14:1165–1174
Mariotto AB, Yabroff KR, Shao Y et al (2011) Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst 103:117–128
https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2018.html. Last accessed 10 Aug 2018
DeSantis C, Siegel R, Bandi P, Jemal A (2011) Breast cancer statistics. CA Cancer J Clin 61:409–418. [PubMed: 21969133]
O’Shaughnessy J (2005) Extending survival with chemotherapy in metastatic breast cancer. Oncologist 10(Suppl 3):20–29. [PubMed: 16368868]
DePalma M, Hanahan D (2012) The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities. Mol Oncol 6(2):111–127
Lawler M, Alsina D, Adams RA (2018) Critical research gaps and recommendations to inform research prioritization for more effective prevention and improved outcomes in colorectal cancer. Gut 67:179–193
Lord CJ, Ashworth A (2010) Biology-driven cancer drug development: back to the future. BMC Biol 8:38
Ghosh S, Ghosh S (2004) Recent research and development in synthetic polymer-based drug delivery systems. J Chem Res 4:241–246
Apicella A, Cappello B, Delnobile MA et al (1994) Poly(ethylene oxide)-based delivery systems. Polym Drugs Drug Adm 545:111–125
Liechty WB, Kryscio DR, Slaughter BV, Peppas NA (2010) Polymers for drug delivery systems. Annu Rev Chem Biomol Eng 1:149–173
Han HD, Song CK, Park YS et al (2008) A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine. Int J Pharm 350:27–3415
Verma D, Gulati N, Kaul S, Mukherjee S, Nagaich U (2018) Protein based nanostructures for drug delivery. J Pharm (Cairo) 2018:9285854. https://doi.org/10.1155/2018/9285854, 18 pages
Jao D, Xue Y, Medina J, Hu X (2017) Protein-based drug-delivery materials. Materials 10(5):517. https://doi.org/10.3390/ma10050517
Fuchs S, Coester C (2010) Protein-based nanoparticles as a drug delivery system: chances, risks, perspectives. J Drug Deliv Sci Technol 20(5):331–342
Yamazoe H (2018) Multifunctional protein microparticles for medical applications. Biomaterials 155(1):1–12
MaHam A, Tang Z, Wu Z, Wang J, Lin Y (2009) Protein-based nanomedicine platforms for drug delivery. Small 5(15):1706–1721
Talebian S, Foroughi J, Wade SJ, Vine KL, Dolatshahi-Pirouz A, Mehrali M, Conde J, Wallace G (2018) Biopolymers for antitumor implantable drug delivery systems: recent advances and future outlook. Adv Mater 30(31):e1706665. https://doi.org/10.1002/adma.201706665
Kawaski ES, Player A (2005) Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer. Nanomedicine 1:101–109
Chakraborty C, Pal S, Doss GP, Wen ZH, Lin CS (2013) Nanoparticles as ‘smart’ pharmaceutical delivery. Front Biosci (Landmark Ed) 1(18):1030–1050
Fioramonti Calixto GM, Bernegossi J, Marise de Freitas L, Carla Raquel Fontana CR, Chorilli M (2016) Nanotechnology-based drug delivery systems for photodynamic therapy of cancer: a review. Molecules 21:342. https://doi.org/10.3390/molecules21030342
Wolinsky JB, Colson YL, Grinstaff MW (2012) Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release 159:14–26
Cafaggi S, Russo E, Stefani R, Leardi R, Caviglioli G, Parodi B et al (2007) Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex. J Control Release 121:110–123
Mishra N, Pant P, Porwal A, Jaiswal J, Samad M, Tiwari S (2016) Targeted drug delivery: a review. Am J PharmTech Res 6(1):1–24
Singh R, Lillard JW (2009) Nanoparticle-based targeted drug delivery. Exp Mol Pathol 6(3):215–223
Ruiz ME, Gantner ME, Talevi A (2014) Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems). Recent Pat Anticancer Drug Discov 9(1):99–128
Katsogiannou M, Peng L, Catapano CV, Rocchi P (2011) Active-targeted nanotherapy strategies for prostate cancer. Curr Cancer Drug Targets 11(8):954–965
Aguilar ZP (2013) Targeted drug delivery, Chap. 5. In: Nanomaterials for medical applications. Elsevier, New York, pp 181–234, ISBN 9780123850898
Tang MF, Lei L, Guo SR, Huang WL (2010) Recent progress in nanotechnology for cancer therapy. Chin J Cancer 29(9):775–780
Grimes R, Luo YY, Mills DK (2018) Bifunctionalized clay nanoparticles for cancer therapy. Appl Sci 8:281. https://doi.org/10.3390/app8020281
Kalepu S, Manthina M, Padavala V (2013) Oral lipid-based drug delivery systems—an overview. Acta Pharm Sin B 3(6):361–372
Yingchoncharoen P, Kalinowski DS, Richardson DR (2016) Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come. Pharmacol Rev 68(3):701–787
Porter CJ, Trevaskis NL, Charman WN (2007) Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 6(3):231
Shrestha H, Bala R, Arora S (2014) Lipid-based drug delivery systems. J Pharm (Cairo) 2014:801820
Porter CJ, Pouton CW, Cuine JF, Charman WN (2008) Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev 60(6):673–691
Jannin V, Musakhanian J, Marchaud D (2008) Approaches for the development of solid and semi-solid lipid-based formulations. Adv Drug Deliv Rev 60(6):734–746
Savla R, Browne J, Plassat V, Wasan KM, Wasan EK (2017) Review and analysis of FDA approved drugs using lipid-based formulations. Drug Dev Ind Pharm 43(11):1743–1758
Lu C, Perez-Soler R, Piperdi B, Walsh GL, Swisher SG, Smythe WR, Shin HJ, Ro JY, Feng L, Truong M et al (2005) Phase II study of a liposome-entrapped cis-platin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma. J Clin Oncol 23:3495–3501
Lemke A, Kiderlen AF, Kayser O (2005) Amphotericin B. Appl Microbiol Biotechnol 68:151–162
Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE (2001) Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 70(1–2):1–20
Mauro FM (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev 5:151–171
Bamrungsap S, Zilong Z, Chen T, Wang L, Li C, Fu T, Tan W (2012) A focus on nanoparticles as a drug delivery system. Nanomedicine 7(8):1253–1271
Blanco E, Shen H, Ferrari M (2015) Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol 33(9):941
Pérez-Herrero E, Fernández-Medarde A (2015) Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm 93:52–79
Kalaydina RV, Bajwa K, Qorri B, Decarlo A, Szewczuk MR (2018) Recent advances in “smart” delivery systems for extended drug release in cancer therapy. Int J Nanomedicine 13:4727
Mody VV, Siwale R, Singh A, Mody HR (2010) Introduction to metallic nanoparticles. J Pharm Bioallied Sci 2(4):282–289
Conde J, Doria G, Baptista P (2012) Noble metal nanoparticles applications in cancer. J Drug Deliv 2012:751075. https://doi.org/10.1155/2012/751075, 12 pages
Gerweck LE (1985) Hyperthermia in cancer therapy: the biological basis and unresolved questions. Cancer Res 45(8):3408–3414
Wust P et al (2002) Hyperthermia in combined treatment of cancer. Lancet Oncol 3(8):487–497
Haranaka K, Sakurai A, Satomi N (1987) Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapy. J Biol Response Mod 6(4):379–391
Chen J et al (2007) Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. Nano Lett 7(5):1318–1322
Tietze R, Lyer S, Dürr S et al (2013) Efficient drug-delivery using magnetic nanoparticles—biodistribution and therapeutic effects in tumour bearing rabbits. Nanomedicine 9:961–971
Evans ER et al (2018) Metallic nanoparticles for cancer immunotherapy. Mater Today 21(6):673–685
Guan X (2015) Cancer metastases: challenges and opportunities. Acta Pharm Sin B 5(5):402–418
Jiang WG, Sanders AJ, Katoh M, Ungefroren U, Gieseler F, Prince M, Thompson SK, Zollo M, Spano D (2015) Tissue invasion and metastasis: molecular, biological and clinical perspectives. Semin Cancer Biol 35:S244–S275
Macedo F, Ladeira K, Pinho F, Saraiva N, Bonito N, Pinto L, Goncalves F (2017) Bone metastases: an overview. Oncol Rev 11(1):321. https://doi.org/10.4081/oncol.2017.321
Croucher PI, McDonald MM, Martin TJ (2016) Bone metastasis: the importance of the neighbourhood. Nat Rev Cancer 16:373–386
Gdowski AS, Ranjan A, Vishwanatha JK (2017) Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials. J Exp Clin Cancer Res 36:108. https://doi.org/10.1186/s13046-017-0578-1
Smith MA, Gurney JG et al (2017) Malignant bone tumors. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. National Cancer Institute, SEER Program, Bethesda.: NIH Pub No. 99-4649, pp 99–110
Steeg PS (2016) Targeting metastasis. Nat Rev Cancer 16:201–218
Redig AJ, McAllister SS (2013) Breast cancer as a systemic disease: a view of metastasis. J Intern Med 274(2):113–126. https://doi.org/10.1111/joim.12084
Bissell MJ, Radisky D (2001) Putting tumours in context. Nat Rev Cancer 1:46–54
Massagué J, Obenauf AC (2016) Metastatic colonization by circulating tumour cells. Nature 529:298–306
https://www.oncolink.org/cancers/bone/bone-metastases/bone-metastasis-treatment-with-medications. Last accessed 16 Jan 2019
Yamada KM, Cukierman E (2007) Modeling tissue morphogenesis and cancer in 3D. Cell 130(4):601–610
Kimlin LC, Casagrande G, Virador VM (2013) In vitro three-dimensional (3D) models in cancer research: an update. Mol Carcinog 52(3):167–182. https://doi.org/10.1002/mc.21844. Epub 2011 Dec 7
Alemany-Ribes M, Semino CE (2014) Bioengineering 3D environments for cancer models. Adv Drug Deliv Rev 79–80:40–49
Friedrich J, Ebner R, Kunz-Schughart L (2007) Experimental anti-tumor therapy in 3-D: spheroids--old hat or new challenge? Int J Radiat Biol 83:849–871
Fessart D, Begueret H et al (2013) Three-dimensional culture model to distinguish normal from malignant human bronchial epithelial cells. Eur Respir J 42(5):1345–1356. https://doi.org/10.1183/09031936.00118812. Epub 2013 Jan 24
Luca AC, Mersch S et al (2013) Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines. PLoS One 8(3):e59689
Cosson S, Otte EA, Hezaveh H, Cooper-White JJ (2015) Concise review: tailoring bioengineered scaffolds for stem cell applications in issue engineering and regenerative medicine. Stem Cells Transl Med 4:156–164
Knowlton S et al (2015) Bioprinting for cancer research. Trends Biotechnol 33:504–513
Baker BM, Chen CS (2012) Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci 125(Pt 13):3015–3024
Zhou X, Zhu W, Nowicki M, Miao S, Cui H, Holmes B, Glazer RJ, Zhang LG (2016) 3D bioprinting a cell-laden bone matrix for breast cancer metastasis study. ACS Appl Mater Interfaces 844:30017–30026. https://doi.org/10.1021/acsami.6b10673
Sitarski AM, Fairfield H, Falank C, Reagan MR (2018) 3D tissue engineered in vitro models of cancer in bone. ACS Biomater Sci Eng 4(2):324–336. https://doi.org/10.1021/acsbiomaterials.7b00097
Mironov V, Boland T, Trusk T, Forgacs G, Markwald RR (2003) Organ printing: computer-aided jet-based 3D tissue engineering. Trends Biotechnol 21:157–161
Mironov V, Kasyanov V, Drake C, Markwald RR (2008) Organ printing: promises and challenges. Regen Med 3:93–103
Busse A, Letsch A et al (2013) Characterization of small spheres derived from various solid tumor cell lines: are they suitable targets for T cells? Clin Exp Metastasis 30(6):781–791. https://doi.org/10.1007/s10585-013-9578-5. Epub 2013 Mar 22
Perche F, Torchilin VP (2012) Cancer cell spheroids as a model to evaluate chemotherapy protocols. Cancer Bio Ther 13(12):1205–1213
Ingram M et al (2010) Tissue engineered tumor models. Biotech Histochem 85:213–229. https://doi.org/10.3109/10520295.2010.483655
Upreti M et al (2011) Tumorendothelial cell threedimensional spheroids: new aspects to enhance radiation and drug therapeutics. Transl Oncol 4:365–376
Chang R, Emami K, Hand W, Sun W (2010) Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model. Biofabrication 2:045004
Mengus C, Manuele G, Muraro MG, Mele V, Amicarella F, Manfredonia C, Muenst S et al (2018) In vitro modeling of tumor–immune system interaction. ACS Biomater Sci Eng 4(2):314–323. https://doi.org/10.1021/acsbiomaterials.7b00077
Li XJ, Valadez AV, Zuo P, Nie Z (2102) Microfluidic 3D cell culture: potential application for tissue-based bioassays. Bioanalysis 4(12):1509–1525
Ghaemmaghami AM, Hancock MJ, Harrington H et al (2012) Biomimetic tissues on a chip for drug discovery. Drug Discov Today 17(3–4):173–181
Duinen V, Trietsch SJ, Joore J, Vulto P, Hankemeier T (2015) Microfluidic 3D cell culture: from tools to tissue models. Curr Opin Biotechnol 35:118–126
Mills DK (2015) Future medicine: the impact of 3D printing. J Nanomater Mol Nanotechnol 4(3):1–3. https://doi.org/10.4172/2324-8777.1000163
Ventola CL (2014) Medical applications for 3D printing: current and projected uses. Pharm Ther 39(10):704–711
Mironov V, Derby B (2006) Bioprinting: a beginning. Tissue Eng 12(4):631–639
Kang HW, Lee SJ, Ko IK, Kengla C, Yoo JJ, Atala AA (2016) 3D bioprinting system to produce human-scale tissue constructs with structural integrity. Nat Biotechnol 34:312
Hung BP, Naved BA, Nyberg EL, Dias M, Holmes CA, Elisseeff JJ et al (2016) Three-dimensional printing of bone extracellular matrix for craniofacial regeneration. ACS Biomater Sci Eng 2:1806–1804
Ji S, Guvendiren M (2017) Recent advances in bioink design for 3D bioprinting of tissues and organs. Front Bioeng Biotechnol 5:23–31
Murphy SV, Atala A (2014) 3D bioprinting of tissues and organs. Nat Biotechnol 32:773–785
Khatiwala C, Law R, Shepard B, Dorfman S, Ceste M (2012) 3D cell bioprinting for regenerative medicine research and therapies. Gene Ther Regul 7(1):1230004. (19 pages). https://doi.org/10.1142/S1568558611000301
Schubert C, van Langeveld MC, Donoso LA (2012) Innovations in 3D printing: a 3D overview from optics to organs. Br J Ophthalmol 98(2):159–161
Ozbolat IT, Yu Y (2013) Bioprinting toward organ fabrication: challenges and future trends. IEEE Trans Biomed Eng 60:691–699
Cu X, Boland T, D’Lima DD, Lotz MK (2012) Thermal inkjet printing in tissue engineering and regenerative medicine. Recent Pat Drug Deliv Formul 6(2):149–155
O’Brien CM, Holmes B, Faucett S, Zhang LG (2015) Three-dimensional printing of nanomaterial scaffolds for complex tissue regeneration. Tissue Eng Part B Rev 21:103
Gurkan UA et al (2014) Engineering anisotropic biomimetic fibrocartilage microenvironment by bioprinting mesenchymal stem cells in nanoliter gel droplets. Mol Pharm 11(7):2151–2159
Xu F, Sridharan B, Wang S, Gurkan UA, Syverud B, Demirci U (2011) Embryonic stem cell bioprinting for uniform and controlled size embryoid body formation. Biomicrofluidics 5(2):22207
Gudapati H, Dey M, Ozbolat I (2016) A comprehensive review on droplet-based bioprinting: past, present and future. Biomaterials 102:20–42
Wijshoff H (2010) The dynamics of the piezo inkjet printhead operation. Phys Rep 491(4):77–177
Tasoglu S, Demirci U (2013) Bioprinting for stem cell research. Trends Biotechnol 31(1):10–19
Kamisuki S, Hagata T, Tezuka C, Nose Y, Fujii M, Atobe M (1998) A low power, small, electrostatically-driven commercial inkjet head. In: Proceedings of the eleventh annual international workshop on Micro Electro Mechanical Systems, 1998. MEMS 98, pp 63–68
Guillotin B, Guillemot F (2011) Cell patterning technologies for organotypic tissue fabrication. Trends Biotechnol 29(4):183–190
Guillotin B et al (2010) Laser assisted bioprinting of engineered tissue with high cell density and microscale organization. Biomaterials 31:7250–7256
Sears NA, Seshadri DR, Dhavalikar PS, Cosgriff-Hernandez E (2016) A review of three-dimensional printing in tissue engineering. Tissue Eng Part B Rev 22(4):298–310
Sears NA, NA SDR, Dhavalikar PS, Cosgriff-Hernandez E (2016) A review of three-dimensional printing in tissue engineering. Tissue Eng Part B Rev 22(4):298–310
Nahmias Y, Odde DJ (2006) Micropatterning of living cells by laser-guided direct writing: application to fabrication of hepatic-endothelial sinusoid-like structures. Nat Protoc 1(5):2288
Koch L, Gruene M, Unger C, Chichkov B (2011) Laser assisted cell printing. Curr Pharm Biotechnol 14(1):91–97
Saunders R, Bosworth L, Gough J, Derby B, Reis N (2004) Selective cell delivery for 3D tissue culture and engineering. Eur Cell Mater 7(Suppl 1):84–85
Demirci U, Montesano G (2007) Single cell epitaxy by acoustic picolitre droplets. Lab Chip 7(9):1139–1145
Guillemot F, Souquet A, Catros S, Guillotin B (2010) Laser-assisted cell printing: principle, physical parameters versus cell fate and perspectives in tissue engineering. Nanomedicine 5(3):507–515
Mir TA, Nakamura M (2017) Three-dimensional bioprinting: toward the era of manufacturing human organs as spare parts for healthcare and medicine. Tissue Eng Part B Rev 23(3):245–256. https://doi.org/10.1089/ten.TEB.2016.0398. Epub 2017 Mar 21
Ferris CJ, Gilmore KG, Wallace GG (2013) Biofabrication: an overview of the approaches used for printing of living cells. Appl Microbiol Biotechnol 97(10):4243–4258
Arslan-Yildiz A, El Assal R, Chen P, Guven S, Inci F, Demirci U (2016) Towards artificial tissue models: past, present, and future of 3D bioprinting. Biofabrication 8(1):14103
Chartrain NA, Williams CB, Whittington AR (2016) Engineering tissues with bioprinting. BioProcess Int 14(10):2016
Hospodiuk M, Dey M, Sosnoski D, Ozbolat IT (2017) The bioink: a comprehensive review on bioprintable materials. Biotechnol Adv 35(2):217–239
Rutz L, Lewis PL, Shah RN (2017) Toward next-generation bioinks: tuning material properties pre- and post-printing to optimize cell viability. MRS Bull 42(8):563–570
Yang E, Miao S, Zhong J, Zhang Z, Mills DK, Grace Zhang LG (2018) Bio-based polymers for 3D printing of bioscaffolds. Poly Rev (Phila Pa) 58(4):668–687. https://doi.org/10.1080/15583724.2018.1484761
Abdelaal OAM, Darwish SMH (2013) Review of rapid prototyping techniques for tissue engineering scaffolds fabrication. In: Öchsner A, da Silva L, Altenbach H (eds) Characterization and development of biosystems and biomaterials. Advanced structured materials. Springer, Berlin, pp 33–54. https://doi.org/10.1007/978-3-642-31470-4_3
Charbe N, McCarron PA, Tambuwala MM (2017) Three-dimensional bio-printing: a new frontier in oncology research. World J Clin Oncol 8(1):21–36
Zhao Y, Yao R, Ouyang L et al (2014) Three-dimensional printing of Hela cells for cervical tumor model in vitro. Biofabrication 6(3):035001
Xu F, Celli J, Rizvi I, Moon S, Hasan T, Demirci U (2011) A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platform. Biotechnol J 6(2):204–212
Kenny HA, Krausz T, Yamada SD, Lengyel E (2007) Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum. Int J Cancer 121:1463–1472. [PubMed: 17546601]
Serrano D, Terres MC, Lalatsa A (2018) Applications of 3D printing in cancer. J 3D Print Med 2(3):115–127
Albritton JL, Miller JS (2017) 3D bioprinting: improving in vitro models of metastasis with heterogeneous tumor microenvironments. Dis Model Mech 10(1):3–14
Zhou X, Zhu W, Nowicki M, Miao S, Cui H, Holmes B, Glazer RI, Grace Zhang LG (2016) 3D bioprinting a cell-laden bone matrix for breast cancer metastasis study. ACS Appl Mater Interfaces 8(44):30017–30026. https://doi.org/10.1021/acsami.6b10673
Bray LJ, Binner M, Holzheu A, Friedrichs J, Freudenberg U, Hutmacher DW, Werner C (2015) Multi-parametric hydrogels support 3D in vitro bioengineered microenvironment models of tumour angiogenesis. Biomaterials 53:609–620. https://doi.org/10.1016/j.biomaterials.2015.02.124
Pathi SP, Kowalczewski C, Tadipatri R, Fischbach CA (2010) A novel 3-D mineralized tumor model to study breast cancer bone metastasis. PLoS One 5(1):e8849
Arrigoni C, Bersini S, Gilardi M, Moretti M (2016) In vitro coculture models of breast cancer metastatic progression towards bone. Int J Mol Sci 17(9):1405
Mironov V, Visconti RP, Kasyanov V, Forgacs G et al (2009) Organ printing: tissue spheroids as building blocks. Biomaterials:30, 2164–2174. [PubMed: 19176247]
Young EW (2013) Cells, tissues, and organs on chips: challenges and opportunities for the cancer tumor microenvironment. Integr Biol 5:1096–1109
Vidi PA, Maleki T, Ochoa M et al (2014) Disease-on-a-chip: mimicry of tumor growth in mammary ducts. Lab Chip 14(1):172–177
Guillemot F et al (2010) High-throughput laser printing of cells and biomaterials for tissue engineering. Acta Biomater 6:2494–2500
Acknowledgements
Support for this work was provided by the Center for Dental, Oral & Craniofacial Tissue & Organ Regeneration (C-DOCTOR) with the support of NIH NIDCR (U24DE026914).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Luo, Y., Elumalai, A., Humayun, A., Mills, D.K. (2019). Understanding Cancer Cell Behavior Through 3D Printed Bone Microenvironments. In: Guvendiren, M. (eds) 3D Bioprinting in Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-23906-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-23906-0_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23905-3
Online ISBN: 978-3-030-23906-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)